LAS VEGAS — GeneASIC Applied sciences might be strolling into this 12 months’s CES 2022 arm in arm with its first product, the GeneASIC Subsequent-Technology Sequencing Evaluation Acceleration Platform (NGSAAP). The annual occasion deemed probably the most influential tech occasion and is a showcase of the most recent innovation in design and engineering within the client know-how section.

GeneASIC NGSAAP is an ultra-fast on-premise NGS information evaluation resolution that allows direct and immediate entry to each uncommon and routine genotypes. The environment friendly system reduces the time taken for information transmission between end-users and cloud servers. Moreover, as an on-premise turnkey resolution, the system ensures information privateness and safety. GeneASIC NGSAAP accomplishes this by leveraging the corporate’s analysis and improvement capability, mixed with an progressive pioneering technique.

The know-how on the product’s core has progressed previous typical sluggish edge and cloud computing. 30X complete genome sequencing (WGS) information secondary evaluation from FASTQ to VCF will be accomplished inside half-hour. With roughly six billion nucleotides within the human diploid genome, even a seemingly negligible error fee of 0.01% may imply 600,000 errors all through the sequence. A excessive protection ensures the information is dependable and thus clinical-grade. Whereas preserving accuracy, GeneASIC Applied sciences has managed to miniaturize the tedious sequencing evaluation pipeline to a compact measurement. GeneASIC NGSAAP consumes much less power, thereby granting hospitals, normal well being examine facilities, and analysis institutes the ability of genomics anytime, anyplace.

All that is to speed up the fulfilment of precision drugs, a burgeoning subject that many nations have invested in and performed genome initiatives. Such examples embrace “Genomics Well being Futures Mission” in Australia, “The 100,000 Genomes Challenge” within the UK, “100,000 Genomes Challenge” in China, “1+ Million Genomes Initiatives” within the EU, and “All of Us” within the US. Most not too long ago, the UK’s NHS and Genomics England deliberate to supply mother and father the opportunity of having WGS for his or her new child infants by the New child Genomes Programme which goals to sequence between 100,000 and 200,000 infants.

“This is a chance for GeneASIC Applied sciences to get a foothold within the UK market by NGSAAP and contribute to those efforts. Presently, the worth of GeneASIC NGSAAP prices half the quantity of different genome information evaluation high-performance computing merchandise,” mentioned Alex Lee, Director of Analysis and Improvement of GeneASIC Applied sciences.

The GeneASIC Subsequent-Technology Sequencing Evaluation Acceleration Platform might be showcased for the primary time on the Taiwan Tech Enviornment (TTA) Pavilion at Eureka Park, Venetian Expo 1F (Former Sands expo), sales space no: 61423.

About GeneASIC Applied sciences

GeneASIC Applied sciences focuses on hardware-accelerated on-premise options for genomic information evaluation. The corporate goals to supply revolutionary edge computing merchandise to advertise the sequencing of uncommon to routine genomes by leveraging its stable analysis and improvement capability. It anticipates helpful sequencing data will be obtained by anybody, anyplace, and anytime within the upcoming future.

GeneASIC Applied sciences is now creating a USB-sized evaluation acceleration product for third-generation sequencing (also called long-read sequencing). It’s opening new funding spherical and welcomes all companions to affix.

For extra data, go to https://geneasic.com/.